Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults

Status:
Completed

Trial end date:
2016-01-06

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of omecamtiv mecarbil in healthy volunteers in Japan.

Phase 1

Amgen
Cytokinetics